This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Marsh & McLennan Unit Allies With LIFT for Digital Wellness
by Zacks Equity Research
Marsh & McLennan's (MMC) arm collaborates with LIFT session to offer a customized digital fitness program in Canadian offices.
Why Is Marsh & McLennan (MMC) Up 4.7% Since Last Earnings Report?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance Brokerage Outlook Sanguine on M&As, Rising Rates
by Sapna Bagaria
Mergers and acquisitions, increasing premium rates, and investments in technology bode well for the insurance brokerage industry.
Aon to Buy CoverWallet for Serving Small to Medium Businesses
by Zacks Equity Research
Aon (AON) will acquire CoverWallet to access the rapidly-evolving digital insurance market for small and medium-sized businesses.
Marsh & McLennan Hits 52-Week: Will It Continue to Rise?
by Zacks Equity Research
Marsh & McLennan (MMC) touches a 52-week high, backed by consistent operating performance.
Why Earnings Season Could Be Great for Marsh & McLennan (MMC)
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Marsh & McLennan's (MMC) Q3 Earnings Surpass, Decline Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results benefit from solid revenues.
Marsh & McLennan (MMC) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 11.59% and -0.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers (WLTW) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Improved performance across Willis Towers' (WLTW) segments is expected to get reflected in its Q3 results.
Is a Beat in Store for Marsh & McLennan's (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to be hurt by elevated debt levels and its weak Risk & Insurance services business, partly offset by solid revenues.
Why Marsh & McLennan (MMC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in the Cards for Aon (AON) This Earnings Season?
by Zacks Equity Research
Aon (AON) is likely to have benefited from strong segmental performances in Q3, partly offset by high interest expenses.
What's in Store for Arthur J. Gallagher (AJG) in Q3 Earnings?
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q3 earnings are likely to have benefited from organic sales and better pricing.
Marsh & McLennan's Unit Ties Up for Pet Insurance Program
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Marsh partners Zurich North America to launch a pet insurance program.
The Zacks Analyst Blog Highlights: Nvidia, Ford, Marsh & McLennan, American Electric and TransUnion
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nvidia, Ford, Marsh & McLennan, American Electric and TransUnion
Top Research Reports for Nvidia, Ford and Marsh & McLennan
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Ford Motor (F) and Marsh & McLennan Companies (MMC).
Marsh & McLennan Arm to Pilot Digital Placement Platform
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh subsidiary to pilot a blockchain-enabled digital platform to ease the insurance placement procedure.
Marsh & McLennan, Xevant Tie Up to Ease Employer Assistance
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Marsh & McLennan's Unit Joins Next Peak for Cyber Protection
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Oliver Wyman teams up with Next Peak to safeguard against cyber risks.
Marsh & McLennan Inks Deal With Construction Risk Partners
by Zacks Equity Research
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Marsh & McLennan (MMC) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan
Top Analyst Reports for Caterpillar, Walmart & McDonald's
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Caterpillar (CAT), Walmart (WMT) and McDonald's (MCD).
Marsh & McLennan (MMC) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 earnings gain traction from improved revenues.